bioMérieux’s Post

In September 2024, the World Health Organization (WHO) published ‘Guidance for best practices for clinical trials.’ This is a major milestone in health research as it is the first time there is global guidance applicable to the design and conduct of all clinical trials (whether or not they include investigational products), also with relevance to observational studies. The WHO and The Global Health Network are convening for this unmissable briefing to present the key aspects of this new guidance, outlining how this guidance can support and strengthen your research projects. The key learnings include: - How WHO can enable your work in clinical research. - How stakeholders can use the guidance to advance patient-centred clinical research. - How implementation leads to enabling more efficient clinical research ecosystems. - Raising awareness of a Global Action Plan on Clinical Trial Ecosystem Strengthening. - Catalysing discussions on what stakeholder groups can do to take forward actions aligned with their strategies. Speakers: Dr Jeremy Farrar, WHO Chief Scientist Dr Vasee Moorthy, WHO Senior Advisor, Research for Health When: 13 December 2024 - in Australia it will be sometime in the middle of the night unfortunately! Hopefully it will be recorded! Access to guidance here - https://lnkd.in/gVGnGg-f Register for webinar here - https://lnkd.in/gmGNH4my World Health Organization #worldhealthorganization #theglobalhealthnetwork #clinicaltrials

🦠💬 The Power of Patient Voices in the Fight Against AMR Antimicrobial resistance (AMR) is not just a medical issue—it’s a human issue. It can affect anyone, anywhere, at any time. Patient testimonials are vital in this fight. They bring AMR’s devastating impact to life, making it clear that this is not a distant threat but a present and urgent crisis. We, as patients, families, and communities, must take a stand. Advocacy starts with us. We need to: ✔️ Be vocal: Share stories and raise awareness. ✔️ Be active: Push for better policies and action. ✔️ Be united: Work together to drive change. ✔️ Be inspirational: Raise awareness about AMR and the responsible use of antibiotics. Spread education and empowerment within our communities to foster lasting change.   By speaking up, we become the voice for our communities, our environment, and our collective health. This isn’t just about today—it’s about ensuring a healthy tomorrow. The push for change must come from all of us, driving policymakers, healthcare providers, and global stakeholders to act.   Let’s turn our stories into solutions and fight for a future where antibiotics still save lives. Together, we are the solution. 🌍💊 #AMR #PatientAdvocacy #AntibioticResistance #OneHealth #HealthAwareness #Antibiotics #GlobalHealth #Prevention #PatientVoices #HealthcareInnovation #EAAD #AntimicrobialResistance #KeepAntibioticsWorking #AMRPatientGroup #PatientsFirst #EUHealthcare #WAAW2024 European Centre for Disease Prevention and Control (ECDC) Gavin S. DG SANTE European Commission European Patients' Forum Anca Toma Health First Europe European Medicines Agency World Health Organization Active Citizenship Network AMR Patient Alliance Antibiotic Research UK AVEC France European Forum for Primary Care (EFPC) European Lung Foundation Fondazione The Bridge International Alliance of Patients' Organizations (IAPO) NGO Karkinaki Awareness for Childhood and Adolescent Cancer Health Consultancy Network (Malta) Patients for Patient Safety Foundation PELVIC PAIN SUPPORT NETWORK Associazione Respiriamo Insieme The AMR Narrative The Patients Association UNIAMO Federazione Italiana Malattie Rare CZEPAR - Česká platforma antibiotické rezistence

Hi everyone I am glad to share my new article on World Pharmacists day On the 25th of September is the annual World Pharmacists Day. 2024 year’s theme is “Pharmacists: Meeting global health needs“. The pharmacy profession fulfills health requirements in many ways on a daily basis. The FIP World Pharmacists Day initiative, titled “Pharmacists: Meeting global health needs” serves as a platform for the profession to commemorate its contributions to enhancing health worldwide. Moreover, it presents an occasion to underscore our capacity for further enhancing global health outcomes. The International Pharmaceutical Federation (FIP) invites colleagues from all sectors of the pharmacy profession to take part in the campaign and reminding decision-makers and the public how the role of pharmacists in meeting health needs remains crucial for building healthier communities everywhere. The global health landscape is increasingly complex and interconnected, emphasizing the necessity of promoting good health and robust, sustainable healthcare systems worldwide while addressing health disparities. The COVID-19 pandemic underscored this imperative. Consequently, many countries and organizations have devised new global health strategies aimed at tackling pressing challenges both current and future. These challenges encompass issues such as limited access to healthcare, shortages of medical professionals, antimicrobial resistance, climate change, air pollution, HIV, and emerging infectious diseases. Aligned with the United Nations Sustainable Development Goals, these strategies propose various solutions, including: strengthening health systems (including improving access to primary health care), preventing health risks, and preparing for and responding to health crises. #snsinstitutions #designthinkers #designthinking

#pandemicpreparedness 🌍 Without coordination, there is a risk of fragmentation, isolated clinical research undertakings, and duplication of efforts. Ecraid is proud to be part of this extensive project to bolster European preparedness. #infectiousdiseases #clinicalresearch #ECRAIDPrime #ECRAIDBase REMAP-CAP

We coordinate research efforts to be prepared for any future pandemic. 👇 The implementation of adaptive platform trials (APTs) and cohort studies (CSs) in infectious diseases has accelerated across Europe and globally, in response to the COVID-19 pandemic. Having multiple APTs and CSs active simultaneously, is essential for Europe’s ability to mount effective clinical research responses, in an agile manner. 👀 Without coordination, there is a risk of fragmentation, of isolated clinical research undertakings, and duplication of efforts. CoMeCT’s Coordination Mechanism ensures the oversight and facilitates the dialogue across audiences, sharing good practices and knowledge, while promoting collaboration and coordination across studies and providing updated information on initiatives and innovation in infectious disease clinical research. 💡 Learn more about our solutions to coordinate studies for better healthcare on https://comectproject.org/ 🤝 #Coordination #ClinicalResearch #InfectiousDiseases ANRS Maladies infectieuses émergentes Ecraid ECRIN (European Clinical Research Infrastructure Network) Norwegian Institute of Public Health Penta Foundation - Child Health Research ID-CARE UNIVR Università degli Studi di Verona VACCELERATE_EU European Health and Digital Executive Agency (HaDEA)

Ahead of the UN General Assembly High-Level Meeting on antimicrobial resistance (AMR) this autumn, the World Health Organization and other UN agencies have outlined actionable steps to combat this critical health threat. AMR risks diminishing the effectiveness of antimicrobial therapies, turning routine infections into potential life-threatening conditions and jeopardizing the safety of medical procedures such as surgeries, transplants, and cancer treatments. While there’s a global agreement on the necessity for new antimicrobials to confront AMR, the path to delivering these innovations has sparked considerable debate. The report calls on UN Member States to pledge increased public investment in both push and pull incentives to accelerate R&D efforts worldwide. Last year marked a significant stride in Europe’s fight against AMR, highlighted by the proposal to introduce a Transferable Exclusivity Voucher (TEV) as a pull incentive. Analyses suggest that implementing the TEV, in conjunction with other initiatives, could save upwards of 20,000 lives and yield $15.5 billion in total benefits. The European Parliament’s recent plenary vote in April, which saw MEPs pass this proposal, is a commendable advancement towards integrating the TEV within EU policies. We encourage Member States to acknowledge the TEV’s potential to bring substantial advantages to European patients, healthcare systems, and society at large. With the EU High-level Conference on AMR around the corner, delivered under the Belgian Presidency, it’s imperative for European policymakers to sustain their support and momentum for innovative policy solutions to this significant public health issue. #EUPharmaPackage #AMR #AntimicrobialResistance

🌍 New WHO Guidance on Best Practices for Clinical Trials 🌍 The World Health Organization has just issued updated guidance in response to the World Health Assembly’s resolution WHA75.8 (2022), aimed at strengthening clinical trials globally. This comprehensive guidance builds on previous work by WHO, emphasizing the need for high-quality clinical research that provides valuable evidence for health interventions. It offers key strategies to enhance the efficiency of clinical trials, minimize research waste, and establish sustained trial infrastructures—able to function in both endemic conditions and times of emergency, like pandemics. By optimizing research coordination and developing new best practices, this guidance sets a new standard for the global clinical trial ecosystem. 💡 This is a significant step toward advancing public health worldwide! I invite you to check the guidelines in the following link: https://lnkd.in/eB3iateA #ClinicalTrials #ResearchInnovation #PatientSafety #WHO #HealthInterventions #ClinicalResearch #Pharmacovigilance

We were honored to chair the insightful session where Niklas Blomberg , Executive Director of the Innovative Health Initiative (Innovative Health Initiative (IHI) ), shared his perspectives on "Navigating Tomorrow: Insights on Horizon Scanning and Public-Private Collaborative Support Strategies." During his 10-minute talk, Niklas highlighted the critical role of IHI as an EU public-private partnership in funding health research and innovation to address the pressing public health needs of today and tomorrow. This session was part of the European Medicines Agency's 10-year celebration of the EU Network Training Centre (EU NTC), marking a decade of collaborative efforts in advancing medical innovation and regulatory science. Niklas provided an update on the progress from the recent IHI Regulatory Summit, emphasizing the importance of collaborative efforts in driving health innovation forward. We are proud to collaborate with IHI on several key projects where the European Liver Patients' Association (ELPA) plays a significant role: GRIPonMASH: Aiming to transform the detection and management of Metabolic dysfunction-Associated Steatohepatitis (#MASH) to reduce disease burden and improve patient outcomes. LIVERAIM : Developing a biomarker-based platform for the early diagnosis of chronic liver disease, enabling personalized therapy and reducing morbidity and mortality. These collaborations exemplify our commitment to advancing health research and innovation through strategic partnerships. #HealthInnovation #PublicPrivatePartnership #Research #Healthcare #IHI #ELPA #GRIPonNASH #LIVERAIM #EMA #EUNTC EU Health and Food Safety European Health and Digital Executive Agency (HaDEA) WHO Regional Office for Europe Belgian Presidency of the Council of the European Union 2024 European Commission EASL the home of Hepatology Aleksander Krag Marko Korenjak Manuel Romero Gomez Veronika Všetíčková MSc Milan Mishkovikj, M.A. European Parliament Anastassiya Semeiskaya European Medicines Agency Emer Cooke

🦠 Honored to be invited as a panelist to discuss the critical issue of rising fungal infections and the growing problem of resistance to antifungal agents. This is an urgent topic in healthcare, as we face new challenges in diagnosing, treating, and preventing these infections. The workshop promises to be an academic delight, bringing together experts to explore innovative solutions and strategies to combat antifungal resistance. Worth joining for anyone keen to dive deep into this evolving field! Registration link Registration link : https://lnkd.in/g4Q3axBi Looking forward to insightful discussions and knowledge sharing! 🌿 Chhavi Gupta #FungalInfections #AntifungalResistance #Healthcare #MedicalEducation #InfectiousDiseases #AcademicWorkshop

🎉 Firstline is delighted to announce a project to deliver Canada’s first official national antimicrobial prescribing guidelines in collaboration with Public Health Agency of Canada | Agence de la santé publique du Canada and Association of Medical Microbiology and Infectious Disease Canada 🇨🇦. The project will deploy Firstline’s advanced digital platform to facilitate AMMI’s work in localizing the World Health Organization's AWaRe system and antibiotic book for Canadian use, and deliver those guidelines to healthcare providers right at the point of care. Every healthcare provider, across all clinical settings, plays a critical role in antimicrobial stewardship. By integrating these guidelines seamlessly into everyday medical practice, Firstline will enable healthcare professionals to make informed, evidence-based decisions that are vital for effective patient care. This effort not only underscores Firstline’s technological capability but also our dedication to enhancing clinical outcomes. In Canada, AMR currently claims thousands of lives and costs billions of dollars annually. Therefore, this project is not just about developing guidelines; it’s about safeguarding the future of healthcare, ensuring that life-saving medical interventions remain effective, and ultimately, saving lives. See more: https://lnkd.in/gg2tVak5 #Firstline #healthcareinnovation #infectiousdiseases #antimicrobialstewardship